1.16881
Fractogel® EMD TMAE (M)
strong anion exchanger, suspension in 20% ethanol and 150 mM NaCl (40-90 µm)
Synonym(s):
Biochromatography, Fractogel® Ion exchangers, Ion exchanger for LC (Fractogel® TSK/EMD), Fractogel® EMD TMAE (M)
Select a Size
$91.00
$685.00
$2,400.00
Inquire
$91.00
Estimated to ship onDecember 22, 2025
About This Item
Skip To
ligand
(Trimethylammoniumethyl)
Quality Level
product line
Fractogel®
form
resin
parameter
240 cm/hr flow rate
8 bar max. pressure
matrix active group
methacrylate
mean particle size
40-90 μm
capacity
100 mg binding capacity (BSA/mg of resin)
transition temp
flash point 35 °C (calculated)
density
1.430 g/cm3 at 20 °C
bulk density
1000 kg/m3
application(s)
gene therapy
mAb
recombinant protein
separation technique
anion exchange
strong anion exchange
storage temp.
no temp limit
Looking for similar products? Visit Product Comparison Guide
1 of 4
This Item | 1.16887 | 1.10316 | 1.16885 |
|---|---|---|---|
| separation technique anion exchange, strong anion exchange | separation technique anion exchange, strong anion exchange | separation technique anion exchange, strong anion exchange | separation technique anion exchange, strong anion exchange |
| form resin | form resin | form resin | form resin |
| ligand (Trimethylammoniumethyl) | ligand (Trimethylammoniumethyl) | ligand (Trimethylammoniumethyl) | ligand (Trimethylammoniumethyl) |
| matrix active group methacrylate | matrix active group methacrylate | matrix active group methacrylate | matrix active group methacrylate |
| capacity 100 mg binding capacity (BSA/mg of resin) | capacity 100 mg binding capacity (BSA/mg of resin) | capacity 180 mg binding capacity (BSA/mg of resin) | capacity 150 mg binding capacity (BSA/mg of resin) |
| sterility sterile (Caustic Stable) | sterility sterile (Caustic Stable) | sterility sterile (Caustic Stable) | sterility sterile (Caustic Stable) |
General description
Features and Benefits
- High protein loading conditions resulting in good selectivity and resolution with the tentacle technology
- Excellent binding to large viruses at increased loading
- Homogenous binding with high selectivity and purity
- Reduce operating costs and resin replacement with enduring durability - allowing for multiple cycles of column regeneration and sanitization
- Compatibility with 2.5 % (v/v) aqueous benzyl alcohol containing 150 mM NaCl storage solution
Packaging
- 1.16881.0100: Fractogel® EMD TMAE (M) Resin 100ml
- 1.16881.0010: Fractogel® EMD TMAE (M) Resin 10ml
- 1.16881.0500: Fractogel® EMD TMAE (M) Resin 500ml
- 1.16881.0050: Fractogel® EMD TMAE (M) Resin 50ml
Analysis Note
Microscopic evaluation: Uniform spherical particles,no agglomerates,no fines
Extractable matter (water): ≤ 0.03 %
Cerium: ≤ 1 µg/g
Pressure drop(column: ID=1.6 cm, L=10 cm at 5 ml/min): ≤ 1.0 bar
Particle size (d10): 37 - 45 µm
Particle size (d50): 48 - 60 µm
Particle size (d90): 63 - 77 µm
Colony forming units (TAMC + TYMC): ≤ 100 CFU/ml
Endotoxins: ≤ 1.00 EU/ml
Protein binding capacity (bovine serum albumin): 80 - 120 mg/ml
Functional test (b:a): ≤ 0.25
Functional test: Separation of conalbumin and human serum albumin
Legal Information
signalword
Warning
hcodes
Hazard Classifications
Flam. Liq. 3
Storage Class
3 - Flammable liquids
wgk_germany
WGK 1
flash_point_f
95.0 °F
flash_point_c
35 °C
Stay compliant with GMP using the Emprove® Program
Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.
Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.
Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite
Not finding what you are looking for? Visit the Emprove® Program Help page.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.
A cost-model compares modalities like viral vectors and mRNA for production scale decision-making.
This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.
Related Content
This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service